Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1033399.RAA9BKmEnKlsj8Xw4g3gnlp_JsekB9QD8H7L0AD3p7--E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1033399.RAA9BKmEnKlsj8Xw4g3gnlp_JsekB9QD8H7L0AD3p7--E130_assertion type Assertion NP1033399.RAA9BKmEnKlsj8Xw4g3gnlp_JsekB9QD8H7L0AD3p7--E130_head.
- NP1033399.RAA9BKmEnKlsj8Xw4g3gnlp_JsekB9QD8H7L0AD3p7--E130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033399.RAA9BKmEnKlsj8Xw4g3gnlp_JsekB9QD8H7L0AD3p7--E130_provenance.
- NP1033399.RAA9BKmEnKlsj8Xw4g3gnlp_JsekB9QD8H7L0AD3p7--E130_assertion evidence source_evidence_literature NP1033399.RAA9BKmEnKlsj8Xw4g3gnlp_JsekB9QD8H7L0AD3p7--E130_provenance.
- NP1033399.RAA9BKmEnKlsj8Xw4g3gnlp_JsekB9QD8H7L0AD3p7--E130_assertion SIO_000772 23210512 NP1033399.RAA9BKmEnKlsj8Xw4g3gnlp_JsekB9QD8H7L0AD3p7--E130_provenance.
- NP1033399.RAA9BKmEnKlsj8Xw4g3gnlp_JsekB9QD8H7L0AD3p7--E130_assertion wasDerivedFrom befree-2016 NP1033399.RAA9BKmEnKlsj8Xw4g3gnlp_JsekB9QD8H7L0AD3p7--E130_provenance.
- NP1033399.RAA9BKmEnKlsj8Xw4g3gnlp_JsekB9QD8H7L0AD3p7--E130_assertion wasGeneratedBy ECO_0000203 NP1033399.RAA9BKmEnKlsj8Xw4g3gnlp_JsekB9QD8H7L0AD3p7--E130_provenance.